ORKA Form 144: 21,000-Share Option Exercise Listed

ORKA reported Rule 144 sale notices and option-related transactions on 04/15/2026.

Rhea-AI Filing Summary

ORKA reported Rule 144 sale notices and option-related transactions on 04/15/2026. The filing lists an exercise of stock options resulting in 21,000 shares delivered for cash on 04/15/2026. The record also shows multiple prior 10b5-1 sales during March and February totaling reported cash amounts.

Insights

Securities Compliance Analyst

Rule 144 notices and 10b5-1 sales recorded; activity appears routine.

The filing documents a 21,000-share issuance tied to an exercise of stock options on 04/15/2026, settled for cash. It also lists 10b5-1 sales of 7,000, 641, and 7,000 shares on prior dates with corresponding cash amounts.

These items are procedural disclosures under resale/insider rules; cash flows and timing are shown in-line with the transactions. Subsequent filings will show any further resale notices.

Key Figures

Option exercise shares: 21,000 shares 10b5-1 sale proceeds (Mar 16, 2026): $286,085.80 10b5-1 sale proceeds (Mar 16, 2026): $26,473.30 +1 more

4 metrics

Option exercise shares 21,000 shares Exercise of stock options on 04/15/2026, cash-settled

10b5-1 sale proceeds (Mar 16, 2026) $286,085.80 Proceeds reported for 7,000-share sale on 03/16/2026

10b5-1 sale proceeds (Mar 16, 2026) $26,473.30 Proceeds reported for 641-share sale on 03/16/2026

10b5-1 sale proceeds (Feb 17, 2026) $226,558.50 Proceeds reported for 7,000-share sale on 02/17/2026

Key Terms

Rule 144, 10b5-1, Exercise of Stock Options

3 terms

Rule 144 regulatory

"144: Securities To Be Sold"

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

10b5-1 regulatory

"10b5-1 Sales for JOANA GONCALVES"

A 10b5-1 plan is a pre-set schedule that lets company insiders buy or sell shares according to written instructions made when they do not possess material, nonpublic information. Think of it as a timed automatic payment for stock trades: it helps insiders avoid accusations of trading on secret information and gives outside investors a clearer signal about whether sales are routine or potentially informative about the company’s prospects.

Exercise of Stock Options financial

"Exercise of Stock Options | Issuer"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did ORKA disclose in the Form 144 filing?

ORKA disclosed a Rule 144 notice showing an exercise of stock options for 21,000 shares on 04/15/2026. The filing also lists prior 10b5-1 sales in March and February with reported sale proceeds.

How many shares were involved in the March and February 10b5-1 sales?

The filing lists 10b5-1 sales of 7,000 shares on 03/16/2026, 641 shares on 03/16/2026, and 7,000 shares on 02/17/2026. Each sale includes its reported cash amount next to the share count.

Were proceeds reported for the recent sales and exercises?

Yes. The filing shows cash amounts: $286,085.80 for a 7,000-share 10b5-1 sale, $26,473.30 for a 641-share sale, and $226,558.50 for a 7,000-share sale. The exercise of 21,000 shares is indicated as cash-settled.

Does this Form 144 indicate ongoing resale activity for ORKA insiders?

The filing records multiple 10b5-1 sales plus an option exercise on 04/15/2026, which indicates reported resale and exercise events during the disclosed period. Further resale notices would appear in subsequent filings.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 04/15/2026 - 04:54 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001756991
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	ORUKA THERAPEUTICS INC
SEC File Number	000-22873
Address of Issuer	855 Oak Grove Avenue Suite 100 Menlo Park CALIFORNIA 94025
Phone	6506067910
Name of Person for Whose Account the Securities are To Be Sold	JOANA GONCALVES
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	21000	1408260.00	49542691	04/15/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	04/15/2026	Exercise of Stock Options	Issuer			21000	04/15/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for JOANA GONCALVES 855 Oak Grove Avenue Suite 100 Menlo Park CA 94025	Common	03/16/2026	7000	286085.80
JOANA GONCALVES 855 Oak Grove Avenue Suite 100 Menlo Park CA 94025	Common	03/16/2026	641	26473.30
10b5-1 Sales for JOANA GONCALVES 855 Oak Grove Avenue Suite 100 Menlo Park CA 94025	Common	02/17/2026	7000	226558.50

144: Remarks and Signature

Remarks	The securities to be sold were and will be received upon the exercise of stock options over the next three months. The dates of acquisition and payment were and will be the dates of exercise/sale.
Date of Notice	04/15/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	09/19/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Joana Goncalves
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)